Lytix Biopharma AS
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma (NCT04796194) | Lytix Biopharma AS | 2021-06-01 |
| LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04) (NCT03725605) | Lytix Biopharma AS | 2018-12-28 |
Track Lytix Biopharma AS automatically
Every clearance here is in the API, with alerts when new ones post.